Total
0
Shares
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • ScreenPro (SCRN) has entered into an LOI to acquire Concierge Medical Consultants from Datametrex AI (DM)
  • Concierge Medical Consultants provides on-call urgent care, COVID testing and occupational medical consulting services
  • ScreenPro will pay C$1,800,000 for the acquisition through the issuance of common shares
  • The parties intend to enter into a definitive agreement by no later than November 30, 2021
  • ScreenPro Security is a medical technology company that offers proprietary testing methods and medical alerting software
  • ScreenPro (SCRN) is unchanged trading at $0.02 per share

ScreenPro (SCRN) has entered into an LOI to acquire Concierge Medical Consultants from Datametrex AI (DM).

Concierge Medical Consultants is a small group of board-certified emergency physicians who provide on-call urgent care, COVID testing and occupational medical consulting services.

The company’s founder and CEO, Dr. Jibran Sharif, MD, CCFP EM, RDMS, is a full-time emergency physician in Metro Vancouver and a lecturer with the faculty of Emergency Medicine at the University of British Columbia.

Pursuant to the LOI, ScreenPro will pay C$1,800,000 for the acquisition through the issuance of common shares priced at $0.05 per share.

The parties intend to enter into a definitive agreement by no later than November 30, 2021.

Lena Kozovski, CEO of ScreenPro Security, stated,

“We believe that adding a medical concierge element to our existing businesses will drive significant value to our bottom line as we have the infrastructure with laboratories, nurses, back-office and scheduling systems in place now with our testing.

The demand for concierge medical services is expected to continue to strengthen as the market for remote health care grows. We look forward to working with Dr. Sharif and his medical team to grow this business under ScreenPro.”

ScreenPro Security is a medical technology company that offers proprietary testing methods and medical alerting software.

ScreenPro (SCRN) is unchanged trading at $0.02 per share as of 9:30 am ET.

More From The Market Herald
LexaGene - CEO, Dr. Jack Regan.

" LexaGene (TSXV:LXG) closes multiple MiQLab sales

LexaGene (LXG) has received purchase orders from Kuma Veterinary Clinic and the Emergency Veterinary Services of Roanoke.
The Market Herald Video

" FSD Pharma (CSE:HUGE) demonstrates positive effects of Lucid-MS in treating MS in pre-clinical models

FSD Pharma (HUGE) is sharing pre-clinical data demonstrating the potentially disease-modifying effects of its lead drug candidate Lucid-MS.
The Market Herald Video

" Adastra Holdings (CSE:XTRX) reports record third-quarter results

Adastra Holdings (XTRX) has filed its consolidated financial statements and related MD&A for the three and nine months ended September 30, 2021, and 2020.